European Archives - Page 371 of 1210 - European Medical Journal

High-Flow Oxygen Does Not Reduce Hypoxaemic Events

A trial has found that using nasal high-flow oxygen during tubeless upper airway surgery in children does not reduce the frequency of interruptions for rescue oxygenation.

Early Lung Ultrasonography Scores Predict Future Respiratory Complications

Early lung ultrasonography scores have been linked to future respiratory complications in preterm infants.

High Discontinuation Rates of GLP-1 Agonists in Patients Who Are Obese

New findings highlighted a concerning trend in the discontinuation rates of Glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes and obesity.

Social Determinants of Health on Diabetic Retinopathy Care

According to recent findings, social determinants of health significantly influence diabetic retinopathy care.

EHA President 2024 Interview: Antonio Almeida

I think the most important thing to say in respect to this is that EHA is a members’ association, and as such, it’s crucial that we cater…

Pride 2024: How can pharma leaders make a difference?

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

Pride Special: J&J's Edmond Chan on the value in being your authentic self

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

Study Confirms Safety of Paternal Valproate Use Pre-Conception

Findings from a comprehensive nationwide cohort study from Denmark have demonstrated the safety of paternal valproate use during spermatogenesis.

Progestogens and Oral Contraceptives Equally Effective in Endometriosis Pain Management

New findings show that postoperative prescription of a long-acting progestogen, or the combined oral contraceptive pill, can reduce the recurrence of endometriosis-related pain.

Precision Genomic Testing Improves Survival in Paediatric Oncology

New research shows that integrating precision genomic testing with targeted therapies improves treatment responses and progression-free survival in pediatric oncology.